Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ucb ADR (OP: UCBJY ) 73.77 UNCHANGED Streaming Delayed Price Updated: 3:32 PM EDT, Jun 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 73.77 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 73.77 Today's Range 73.77 - 73.77 52wk Range 34.85 - 73.84 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target January 02, 2024 Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of... Via Benzinga Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst September 28, 2023 Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeutics. Via Benzinga Performance YTD +70.56% +70.56% 1 Month +7.31% +7.31% 3 Month +26.71% +26.71% 6 Month +82.87% +82.87% 1 Year +59.43% +59.43% More News Read More Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts August 31, 2023 Via Benzinga FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults June 27, 2023 Via Benzinga Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path February 14, 2023 Via Benzinga UCB's Rare Childhood Epilepsy Drug Scores FDA Approval March 28, 2022 Via Benzinga The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More May 30, 2022 Via Benzinga Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane February 08, 2022 Via Benzinga The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More January 23, 2022 Via Talk Markets The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More January 23, 2022 Via Benzinga UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study January 21, 2022 Via Benzinga ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today January 19, 2022 Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021 September 02, 2021 Via Benzinga UCB Gets EU Approval For Bimekizumab In Psoriasis August 25, 2021 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2021 August 23, 2021 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021 July 23, 2021 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021 July 09, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
